These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12480308)

  • 21. Induction of adaptive immune response by self-aggregating peptides.
    Zepeda-Cervantes J; Vaca L
    Expert Rev Vaccines; 2018 Aug; 17(8):723-738. PubMed ID: 30074424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technical and regulatory hurdles for DNA vaccines.
    Donnelly J; Berry K; Ulmer JB
    Int J Parasitol; 2003 May; 33(5-6):457-67. PubMed ID: 12782047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies.
    Olive C; Toth I; Jackson D
    Mini Rev Med Chem; 2001 Nov; 1(4):429-38. PubMed ID: 12369968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical vaccination of DNA antigens: topical delivery of DNA antigens.
    Choi MJ; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):271-82. PubMed ID: 12907832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-administration of tilapia alpha-helical antimicrobial peptides with subunit antigens boost immunogenicity in mice and tilapia (Oreochromis niloticus).
    Acosta J; Carpio Y; Valdés I; Velázquez J; Zamora Y; Morales R; Morales A; Rodríguez E; Estrada MP
    Vaccine; 2014 Jan; 32(2):223-9. PubMed ID: 24252704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of the immune response by immunization with antigens in defined multimeric physical forms.
    Morein B
    Vet Immunol Immunopathol; 1987 Dec; 17(1-4):153-9. PubMed ID: 3124333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal immunity: overcoming the barrier for induction of proximal responses.
    McKenzie BS; Brady JL; Lew AM
    Immunol Res; 2004; 30(1):35-71. PubMed ID: 15258310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development.
    Czerkinsky C; Svennerholm AM; Holmgren J
    Clin Infect Dis; 1993 Mar; 16 Suppl 2():S106-16. PubMed ID: 8452962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights in mucosal vaccine development.
    Pavot V; Rochereau N; Genin C; Verrier B; Paul S
    Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A boosting skin vaccination with dissolving microneedle patch encapsulating M2e vaccine broadens the protective efficacy of conventional influenza vaccines.
    Zhu W; Pewin W; Wang C; Luo Y; Gonzalez GX; Mohan T; Prausnitz MR; Wang BZ
    J Control Release; 2017 Sep; 261():1-9. PubMed ID: 28642154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.
    Ramsay AJ; Kent SJ; Strugnell RA; Suhrbier A; Thomson SA; Ramshaw IA
    Immunol Rev; 1999 Oct; 171():27-44. PubMed ID: 10582164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine.
    Le Luduec JB; Debeer S; Piras F; Andréoni C; Boudet F; Laurent P; Kaiserlian D; Dubois B
    Vaccine; 2016 Feb; 34(7):914-22. PubMed ID: 26768129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design.
    Purcell AW; Zeng W; Mifsud NA; Ely LK; Macdonald WA; Jackson DC
    J Pept Sci; 2003 May; 9(5):255-81. PubMed ID: 12803494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Skin vaccination].
    Naito S
    Nihon Rinsho; 2008 Oct; 66(10):1888-93. PubMed ID: 18939486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanocarriers: a versatile approach for mucosal vaccine delivery.
    Mody N; Sharma R; Agrawal U; Vyas SP
    Ther Deliv; 2015 Feb; 6(2):231-45. PubMed ID: 25690089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lectins and microparticles for enhanced oral vaccination.
    Lavelle EC
    Methods; 2006 Feb; 38(2):84-9. PubMed ID: 16406570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c.
    Vordermeier HM; Pontarollo R; Karvonen B; Cockle P; Hecker R; Singh M; Babiuk LA; Hewinson RG; van Drunen Littel-van Den Hurk S
    Vaccine; 2005 Aug; 23(35):4375-84. PubMed ID: 15908057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
    Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
    Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.